Point72 Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.2M | Buy |
258,866
+26,768
| +12% | +$1.36M | 0.03% | 513 |
|
|
2025
Q1 | $10.5M | Buy |
+232,098
| New | +$10.5M | 0.02% | 525 |
|
|
2023
Q3 | – | Sell |
-601,038
| Closed | -$15.5M | – | 2022 |
|
|
2023
Q2 | $15.5M | Buy |
601,038
+43,600
| +8% | +$1.13M | 0.05% | 411 |
|
|
2023
Q1 | $13.4M | Buy |
557,438
+217,928
| +64% | +$5.23M | 0.04% | 424 |
|
|
2022
Q4 | $6.62M | Buy |
+339,510
| New | +$6.62M | 0.02% | 590 |
|
|
2022
Q2 | – | Sell |
-153,389
| Closed | -$3.38M | – | 1224 |
|
|
2022
Q1 | $3.38M | Sell |
153,389
-161,454
| -51% | -$3.56M | 0.01% | 709 |
|
|
2021
Q4 | $5.02M | Buy |
314,843
+170,443
| +118% | +$2.72M | 0.02% | 627 |
|
|
2021
Q3 | $2.88M | Buy |
144,400
+125,600
| +668% | +$2.5M | 0.01% | 694 |
|
|
2021
Q2 | $325K | Buy |
18,800
+13,800
| +276% | +$239K | ﹤0.01% | 831 |
|
|
2021
Q1 | $99K | Buy |
+5,000
| New | +$99K | ﹤0.01% | 852 |
|
|
2020
Q3 | – | Sell |
-97,415
| Closed | -$1.9M | – | 966 |
|
|
2020
Q2 | $1.9M | Buy |
+97,415
| New | +$1.9M | 0.01% | 567 |
|